melanotan-ii has been researched along with Disease Models, Animal in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Chhabra, KH; Jones, GL; Kiran, S; Low, MJ; Shangguan, G; Thompson, Z; Yu, H | 1 |
Bouvier, M; Lanfray, D; René, P; Richard, D | 1 |
Carter, CS; Cote, I; Green, SM; Morgan, D; Scarpace, PJ; Toklu, HZ; Tümer, N | 1 |
Hellberg, S; Knuuti, J; Koskinen, E; Liljenbäck, H; Nuutinen, S; Rinne, P; Roivainen, A; Salomäki, H; Saraste, A; Saukko, P; Savontaus, E; Silvola, JM; Ståhle, M | 1 |
Adan, RA; Bergen, DJ; Brakkee, JH; Brans, MA; Cuppen, E; Garner, KM; Mul, JD; Toonen, PW; van Boxtel, R | 1 |
Baird, JP; Grigg, LA; LaRiviere, M; Lim, C; Lord, J; Matute, E; Palacios, M | 1 |
Baumane, L; Dambrova, M; Kalvinsh, I; Liepinsh, E; Muceniece, R; Vilskersts, R; Wikberg, JE; Zvejniece, L | 1 |
7 other study(ies) available for melanotan-ii and Disease Models, Animal
Article | Year |
---|---|
Hypothalamic POMC deficiency increases circulating adiponectin despite obesity.
Topics: Adiponectin; Adipose Tissue; alpha-MSH; Animals; Arcuate Nucleus of Hypothalamus; Caloric Restriction; Disease Models, Animal; Female; Melanocortins; Metabolism, Inborn Errors; Mice; Mice, Knockout; Neurons; Obesity; Peptides, Cyclic; Pro-Opiomelanocortin; Signal Transduction; Sympathetic Nervous System | 2020 |
Pharmacological chaperone action in humanized mouse models of MC4R-linked obesity.
Topics: alpha-MSH; Animals; Blood Glucose; Body Weight; Carrier Proteins; Cell Membrane; Disease Models, Animal; Female; HEK293 Cells; Humans; Male; Mice; Mutation; Obesity; Peptides, Cyclic; Phenotype; Protein Conformation; Receptor, Melanocortin, Type 4 | 2021 |
Limiting feeding to the active phase reduces blood pressure without the necessity of caloric reduction or fat mass loss.
Topics: Activity Cycles; Adiposity; alpha-MSH; Animals; Arterial Pressure; Diet, High-Fat; Disease Models, Animal; Energy Intake; Energy Metabolism; Fasting; Feeding Behavior; Hypertension; Male; Obesity; Peptides, Cyclic; Photoperiod; Rats, Inbred BN; Rats, Inbred F344; Time Factors | 2018 |
Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
Topics: alpha-MSH; Animals; Anti-Inflammatory Agents; Aorta; Apolipoproteins B; Atherosclerosis; Biomarkers; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Inflammation; Inflammation Mediators; Lipids; Macrophages; Male; Mice; Mice, Knockout; Peptides, Cyclic; Phenotype; Plaque, Atherosclerotic; Radionuclide Imaging; Receptors, LDL; Receptors, Melanocortin; Signal Transduction; Vasodilation; Vasodilator Agents | 2014 |
Melanocortin receptor 4 deficiency affects body weight regulation, grooming behavior, and substrate preference in the rat.
Topics: alpha-MSH; Animals; Animals, Genetically Modified; Disease Models, Animal; Eating; Energy Metabolism; Food Preferences; Grooming; Obesity; Peptides, Cyclic; Rats; Receptor, Melanocortin, Type 4; Weight Gain | 2012 |
Anatomical dissociation of melanocortin receptor agonist effects on taste- and gut-sensitive feeding processes.
Topics: alpha-MSH; Animals; Anorexia; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Gastrointestinal Tract; Male; Peptides, Cyclic; Prosencephalon; Rats; Rats, Sprague-Dawley; Receptors, Melanocortin; Rhombencephalon; Saccharin; Sucrose; Taste | 2011 |
Functional evaluation of THIQ, a melanocortin 4 receptor agonist, in models of food intake and inflammation.
Topics: alpha-MSH; Animals; Anti-Inflammatory Agents; Body Weight; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Electron Spin Resonance Spectroscopy; Inflammation; Injections, Intraventricular; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Nitric Oxide; Peptides, Cyclic; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Tetrahydroisoquinolines; Triazoles | 2007 |